Utah Medical Products, Inc. (UTMD)
74.23
-0.83
(-1.11%)
USD |
NASDAQ |
Oct 23, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Utah Medical Products Market Cap : 236.27M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 236.27M |
| October 22, 2026 | 238.92M |
| October 21, 2026 | 237.83M |
| October 20, 2026 | 238.95M |
| October 19, 2026 | 237.29M |
| October 16, 2026 | 237.17M |
| October 15, 2026 | 238.47M |
| October 14, 2026 | 238.06M |
| October 13, 2026 | 237.80M |
| October 12, 2026 | 236.85M |
| October 09, 2026 | 237.26M |
| October 08, 2026 | 235.14M |
| October 07, 2026 | 233.79M |
| October 06, 2026 | 235.00M |
| October 05, 2026 | 233.35M |
| October 02, 2026 | 235.96M |
| October 01, 2026 | 236.66M |
| September 30, 2026 | 235.70M |
| September 29, 2026 | 238.57M |
| September 28, 2026 | 237.10M |
| September 25, 2026 | 236.11M |
| September 24, 2026 | 237.93M |
| September 23, 2026 | 238.76M |
| September 22, 2026 | 244.01M |
| September 21, 2026 | 237.07M |
| Date | Value |
|---|---|
| September 18, 2026 | 235.41M |
| September 17, 2026 | 236.15M |
| September 16, 2026 | 235.73M |
| September 15, 2026 | 237.55M |
| September 14, 2026 | 224.94M |
| September 11, 2026 | 221.89M |
| September 10, 2026 | 221.66M |
| September 09, 2026 | 221.92M |
| September 08, 2026 | 220.14M |
| September 04, 2026 | 226.31M |
| September 03, 2026 | 225.07M |
| September 02, 2026 | 228.03M |
| September 01, 2026 | 228.41M |
| August 31, 2026 | 226.41M |
| August 28, 2026 | 231.63M |
| August 27, 2026 | 228.54M |
| August 26, 2026 | 225.64M |
| August 25, 2026 | 225.87M |
| August 24, 2026 | 227.97M |
| August 21, 2026 | 227.74M |
| August 20, 2026 | 227.33M |
| August 19, 2026 | 229.56M |
| August 18, 2026 | 229.18M |
| August 17, 2026 | 223.48M |
| August 14, 2026 | 225.99M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 179.44B |
| AngioDynamics, Inc. | 524.58M |
| Alphatec Holdings, Inc. | 1.696B |
| AtriCure, Inc. | 2.999B |
| Baxter International, Inc. | 13.08B |
Market Cap Related Metrics
| PE Ratio | 22.23 |
| PS Ratio | 6.775 |
| Price to Book Value | 1.912 |
| Price | 74.23 |
| Earnings Yield | 4.50% |
| Operating PE Ratio | 22.22 |
| Normalized PE Ratio | 21.94 |